Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial
Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the completed B-Well 2 bepirovirsen study is displayed, with its study design, outcomes, eligibility criteria, locations, and data-sharing details.SummaryDifference100%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice announces an NIH terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence.” It appears above the ClinicalTrials.gov error page.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content with a generic error page. This reflects an access issue rather than a substantive update to the study details.SummaryDifference16%

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.